SCHEMBL7124459

SCHEMBL7124459

CC(C)(C)NC(=O)C(CCc1ccccc1)NS(=O)(=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
MMP2 P08253 8/20 0.54
MMP9 P14780 7/20 0.54
PLAU P00749 1/20 0.53
HPN P05981 1/20 0.53
MAPT P10636 1/20 0.51
MEN1 O00255 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
KMT2A Q03164 1/20 0.50
PSMB8 P28062 3/20 0.49
MMP7 P09237 1/20 0.49
PSMB5 P28074 3/20 0.48
ADAMTS4 O75173 1/20 0.47
MMP14 P50281 2/20 0.46
MMP8 P22894 1/20 0.46
MMP12 P39900 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127817 0.93 MMP2 (0.53) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL7127019 0.90 PLAU (0.60) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL7121669 0.90 ALDH1A1 (0.63) ALDH1A1MMP2MMP9PLAUHPN
SCHEMBL7125293 0.89 PLAU (0.59) ALDH1A1MMP2MMP9PLAUHPN
SCHEMBL7124501 0.89 PLAU (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL7118405 0.89 MMP2 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL7117861 0.84 PSMB8 (0.54) ALDH1A1MMP2MMP9PLAUHPN
SCHEMBL7116828 0.83 USP30 (0.43) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL7126168 0.83 MMP2 (0.49) ALDH1A1CYP1A2CYP2C19MMP2MMP9
SCHEMBL8146180 0.82 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583318-B2 Carrying out a four component condensation reaction between components consisting of a sulfonamide, an aldehyde or ketone, an isocyanide and a carboxylic acid, and one of such components being attached to a solid support ADVANCED SYNTECH, LLC 2003-06-24 US disclosed
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ADVANCED SYNTECH LLC 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ASPH, COASY, HAAO ALDH1A1 391/4885CYP1A2 2348/4885CYP2C9 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.